Trial intelligence / Profile preview

BMAC Combined With Arthroscopic Surgery For Painful Shoulder Osteoarthritis

NCT04826224Phase 1Terminated

Start
Dec 2021
Primary completion
Aug 2025
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of autologous bone marrow cell concentrate in shoulder osteoarthritis. Primary endpoints: Adverse Reactions and Morbidity related to bone marrow aspirations from iliac crests. Started Dec 2021; status: terminated.

02

Drugs

autologous bone marrow cell concentrate
03

Conditions

shoulder osteoarthritis

Beyond the preview

Go deeper on NCT04826224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04826224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call